Generex Biotechnology Corporation (OTCPK:GNBT) entered into a letter of intent to acquire assets of Pantheon Medical-Foot & Ankle for $1.4 million on January 9, 2019. Under the terms of the deal, Generex will acquire all of the assets of Pantheon Medical including business operations, accounts receivable and inventory, contracts, and an FDA letter related to balanced plating system, on a debt free basis, $1.4 million worth of Generex (GNBT) stock, plus additional cash and stock consideration upon achieving certain sales and profit goals. As of April 29, 2019, the deal turned out to be an all stock transaction. Transaction is expected to be completed shortly after the close of this fiscal quarter (April 30, 2019). As of June 3, 2019, the deal is expected to close in the coming weeks.